Patient FAQs & Additional Resources
FAQs for Your Patients
Videos (View)
- Why Every Physician Needs to Integrate Clinical Drug Monitoring into their Practice
- How to Set the Stage for a Clinical Drug Monitoring Program with Your Patient
- How to Share Clinical Drug Monitoring Results with Your Patient
Additional Resources
- About Opioid Patient-Prescriber Agreements
- Sample Opioid Patient Agreement forms
- Sample Risk-Assessment Screening Tools for Drug Abuse or Misuse
Guidelines that call for clinical drug monitoring and testing in patients
- Guideline for Prescribing Opioids for Chronic Pain (see Recommendation 10)
- American Academy of Pain Medicine
- American Chronic Pain Association
- American Society of Interventional Pain Physicians
- Federation of State Medical Boards
- US Departments of Veterans Affairs and Defense
- Washington State Agency Medical Directors’ Group
Peer support for clinical drug monitoring and testing in patients
- “Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations,” by Argoff CE, Alford DP, Fudin J, et al, 2017.
- “Urine drug testing in clinical practice: The art and science of patient care,” by Gourlay D, Heit H, Caplan Y at the Center for Independent Healthcare Education, 2015.
- “Urine drug testing: current recommendations and best practices,” by Owen GT, Burton AW, Schade CM, Passik S, 2012.
Related Articles
- Urine Drug Monitoring: Strategies for ordering, understanding, and communicating opioid therapy screening results
- Assessment and Monitoring of Pain: Urine Drug Screening
- Urine Drug Testing: What is Optimal Frequency and Duration?
- Interpreting Negative Urine Drug Test Results
- Random versus Scheduled: Maximizing the Efficacy of Urine Drug Monitoring
- Demystifying Benzodiazepine Urine Drug Screen Results
- Half of Americans Tested Misuse Their Prescription Medications
- What’s the safest, effective way to taper a patient off of opioid therapy?
Last updated on: October 2, 2018
